Alienys Izquierdo Oliva

Title: The Innovative Contributions of Alienys Izquierdo Oliva

Introduction

Alienys Izquierdo Oliva is a notable inventor based in Artemisa, Cuba. He has made significant strides in the field of biotechnology, particularly in the development of vaccines. His work focuses on addressing critical health challenges, such as the dengue virus.

Latest Patents

Alienys holds a patent for a dengue virus vaccine composition. This innovative vaccine comprises at least one antigen based on the dengue virus capsid protein and an oligonucleotide identified as SEQ ID NO 1. The composition includes a fusion protein formed by the DV2 capsid and domain III of the envelope protein of the same serotype. This formulation has been shown to elicit higher levels of cellular immune response and protection in mice compared to previous formulations. The efficacy of this vaccine composition has also been demonstrated in non-human primates. The compositions can be monovalent, bivalent, or tetravalent and are designed to induce a functional immune response to the four viral serotypes.

Career Highlights

Throughout his career, Alienys has worked with prominent institutions such as the Centro de Ingeniería Genética y Biotecnología. His contributions to vaccine development have positioned him as a key figure in the field of genetic engineering and biotechnology.

Collaborations

Alienys has collaborated with Lázaro Gil González, further enhancing the impact of his research and innovations.

Conclusion

Alienys Izquierdo Oliva's work in developing a dengue virus vaccine composition showcases his commitment to advancing public health through innovative biotechnology solutions. His contributions are vital in the ongoing fight against infectious diseases.